Associate Professor Michael Jameson explains SPAR

The SPAR trial aims to build on research that indicates that a statin drug, taken for cholesterol, can lead to better patient responses to chemotherapy and radiotherapy in rectal cancer.

In this video, the trial’s Principal Investigator, Associate Professor Michael Jameson, discusses what the trial involves and why it could change outcomes for rectal cancer patients.



Click here for more information on SPAR.